Savara Inc. (SVRA) stock analysis and AI prediction
The company facts of Savara Inc., with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $1.0 billion
- Size
- Small cap
- Employees
- 70
- Headquarters
- AUSTIN, TX
- Listed since
- Nov. 18, 1996
- Website
- savarapharma.com
More Healthcare stocks
Other small cap stocks
Keep going
SVRA questions
What is the AI prediction for SVRA stock?
Each market day our model rates Savara Inc. (SVRA) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the SVRA prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for SVRA?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see SVRA options?
The SVRA options page opens its calls and puts, with price, volume, implied volatility and the Greeks.